Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098823 · ClinicalTrials.gov registry record · Phase 4
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE
A Phase 4 study, sponsored by Ampel BioSolutions.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT03098823 is a Phase 4 study that has completed, run by Ampel BioSolutions. The registered enrollment target is 62 participants.
The verdict
NCT03098823, a Phase 4 study, has completed, sponsored by Ampel BioSolutions.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
To compare the effect of RAYOS® versus immediate-release (IR) prednisone on fatigue as measured by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).
Interventions
- DRUG Prednisone
- DRUG RAYOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2020-06-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03098823
The ClinicalTrials.gov registry entry for NCT03098823 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ampel BioSolutions, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT03098823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03098823 about?
NCT03098823 is a clinical study titled "A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE". To compare the effect of RAYOS® versus immediate-release (IR) prednisone on fatigue as measured by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).
What is the current status of trial NCT03098823?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2017-09-12. Estimated completion is 2020-06-15.
What interventions are being tested in trial NCT03098823?
The interventions under investigation include: Prednisone (DRUG), RAYOS (DRUG).
Who is sponsoring clinical trial NCT03098823?
This trial is sponsored by Ampel BioSolutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.